利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: This talk introduces home-use products to the professional practitioner and explores how they may be a useful adjunct to in-office procedures. Fractional, non-fractional and mechano-biology products (mechanical stimuli) are considered.

Introduction: Media exposure of energy-based technologies and medical as well as scientific validation that lasers, intense light devices and other technologies produce measurable results in skin rejuvenation has led to the introduction of miniaturised, low-cost devices for in-home use by the consumer. Several leading brands and new technologies are now entering this expanding market sector but are these low-cost systems credible and how do they compare with professional treatments?

Materials / method: Home device options for skin rejuvenation include:
• Low level light therapy (LLLT) LEDs:
o Red light as stand alone
o in combination with IR light / RF
• Non-ablative fractional lasers
• Mechanical stress
So far, red LEDs, typically 630-655 nm, have been most popular as they are cheap and plentiful
Several FDA-cleared non-ablative fractional home laser devices with invisible infrared outputs (1410-1440 nm) are available to the consumer. Numerous studies have been published supporting statistically significant efficacy results for these devices.

Results: The histopathology response of home-use fractional is consistent with professional RX Fractional and non-ablative devices.
These home-use devices require significantly more treatments than is commonplace in the clinic environment where higher fluences, larger spot sizes and faster repetition rates permit a speedier and more efficient treatment with the reassurance of professional counselling and support.
Many consumers will be uncertain about safety, suitability for use with underlying medical conditions (e.g. diabetes, epilepsy, hormonal conditions, etc) and contra-indicated medication.

Conclusion: As practitioners delivering in-office skin rejuvenation treatments, we should also explore opportunities to use proven home-use devices alongside our own professional treatments e.g. for on-going home-care top-up treatments as part of a total professional treatment regimen.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: Clarisonic, Illuminage, Home Skinovations, EndyMed, Neutrogena (J&J) JoyLux

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： Clarisonic, Illuminage, Home Skinovations, EndyMed, Neutrogena (J&J) JoyLux

Objectives: There is a large pent-up demand for home use devices (HUDs), yet no medical anti-aging devices have achieved mass-market success for home use to date. First, this presentation will analyze the customer requirements for anti-aging HUDs needed to enable mass-market appeal. Next, the presentation will take a technical look at how those needs may be met, then lastly, it will review the latest home use lasers for anti-aging and show which have the most promise to move HUDs toward mass-market appeal.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: SemiNex Corporation

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: Dermal Photonics Corporation

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否
请注明日期: Board of Directors and General Management
和审阅情况: Dermal Photonics Corporation 2012 to present

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。